MedTrace Logo

Screening of Cardiac Abnormalities in the First Trimester of Pregnancy by Volumetric Acquisition

NCT05666297 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2022-12-27

No results posted yet for this study

Summary

Ultrasound is one of the most important tools in pregnancy both for its diagnostic capacity, but also because it is not invasive.

For physiological pregnancy, the Italian guidelines provide for the execution of 3 ultrasounds: one in the first trimester (between 11 and 14 weeks), one in the second trimester (between 20 and 22 weeks) and one in the third (between 30 and 36 weeks). weeks).

Screening for cardiac abnormalities is done during second trimester ultrasound, also called structural ultrasound. However, the development of three-dimensional (3D) sonography has represented a dramatic shift in obstetrics as it allows for the acquisition of a volume of data rather than conventional planar or 2D scans. This method has allowed considerable progress in the study of the fetus in the initial stages of development and has opened new windows in the knowledge of anatomical malformations at an early age.

The possibility of detecting structural anomalies already during the first trimester of pregnancy allows, in fact, to provide the patient with additional time for counseling and for any genetic tests.

Conditions

  • Pregnancy
  • Ultrasound
  • Fetal Conditions
  • Cardiac Abnormalities

Sponsors & Collaborators

  • University of Campania Luigi Vanvitelli

    lead OTHER

Principal Investigators

  • Fabiana Savoia, MD · University of Campania Luigi Vanvitelli

  • Antonio Schiattarella, MD · University of Campania Luigi Vanvitelli

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2023-02-15
Completion
2023-05-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05666297 on ClinicalTrials.gov